LeadIQ logo
Learn more at LeadIQ.com
Crescendo Biologics Limited

Crescendo Biologics Limited Employee Directory

Biotechnology ResearchCambridge, United Kingdom51-200 Employees

Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.

Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical candidate from Crescendo’s T cell enhancing pipeline. Crescendo is also developing CB213, a preclinical PD-1 x LAG-3 multi-specific Humabody.

The Company’s ability to develop multi-functional Humabody therapeutics is based on its unique, patent protected, transgenic mouse platform generating fully human VH domain building blocks (Humabody VH). These robust molecules can be configured to engage therapeutic targets in such a way that they deliver novel pharmacology and superior bio-distribution. This can lead to larger therapeutic windows compared to conventional IgG approaches. Humabody-based formats can also be applied across a range of non-cancer indications. 

Beyond Crescendo’s proprietary pipeline, the Company has global, multi-target discovery and development collaborations with both Takeda and BioNTech and an exclusive, worldwide licensing agreement with Zai Lab for ZL-1102 (formerly CB001, an anti-IL-17A targeting Humabody), which is expected to enter global Phase 2 clinical development in patients with psoriasis. 

Crescendo Biologics is located in Cambridge, UK, and is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda and Quan Capital. For more information, please visit www.crescendobiologics.com.

Find Crescendo Biologics Limited employees' phone numbers or email addresses

Crescendo Biologics Limited Global Highlights

Location
Employees

Europe
88

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    84
  • Italy
    2
  • France
    1
  • Romania
    1

North America
3

Minus sign iconPlus sign icon
  • United States Of America
    3

Africa
1

Minus sign iconPlus sign icon
  • South Africa
    1

Crescendo Biologics Limited's Leadership

Crescendo Biologics Limited Employee Metrics

100%
50%
0%
2024
2023
  • Research
  • Administrative
  • Program & Project Management
  • Engineering
  • Business
  • Other
  • Arts & Design

Contact profiles from Crescendo Biologics Limited

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Crescendo Biologics Limited known for?

Minus sign iconPlus sign icon
Crescendo Biologics Limited was founded in 2009 operates in the Biotechnology Research industry. The company's main headquarters is located in Babraham Research Campus Cambridge, GB; you can contact the main corporate office by phone at . Explore Crescendo Biologics Limited's company overview page for more information.

What is Crescendo Biologics Limited's most common email format?

Minus sign iconPlus sign icon
Crescendo Biologics Limited employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Crescendo Biologics Limited email formats with LeadIQ.

How many employees does Crescendo Biologics Limited have currently?

Minus sign iconPlus sign icon
Crescendo Biologics Limited has approximately 56 employees as of September 2024. These team members are located across 3 continents, including EuropeNorth AmericaAfrica.

Who are Crescendo Biologics Limited's key employees and leadership?

Minus sign iconPlus sign icon

As of September 2024, Crescendo Biologics Limited's key employees include:

  • Chief Development Officer (cdo): P. B.
  • Chief Operating Officer: J. T.
  • Ceo: T. H.
  • Evp Cmc & Development: R. W.
  • Director, Business Development: A. Y.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.